We are relentlessly pursuing excellence – daring to believe that a cure can be a reality.
Infinity Pharmaceuticals, Inc., is a clinical-stage biotechnology company developing eganelisib (IPI-549), a potentially first-in-class, oral, immuno-oncology macrophage reprogramming therapeutic which addresses a fundamental biologic mechanism of immune suppression in cancer in multiple clinical studies. MARIO-275 is a randomized, controlled combination study of eganelisib combined with Opdivo® in I/O naïve urothelial cancer. MARIO-3 is the first eganelisib combination study in front-line advanced cancer patients and is evaluating eganelisib in combination with Tecentriq® and Abraxane® in front-line TNBC and in combination with Tecentriq and Avastin® in front-line RCC. In collaboration with Arcus Biosciences, Infinity is evaluating a checkpoint inhibitor-free, novel combination regimen of eganelisib plus etrumadenant (AB928, a dual adenosine receptor antagonist) plus Doxil® in advanced TNBC patients. In 2019, Infinity completed enrollment in MARIO-1, a Phase 1/1b study evaluating eganelisib as a monotherapy and in combination with Opdivo (nivolumab) in patients with advanced solid tumors including patients refractory to checkpoint inhibitor therapy. With these studies, Infinity is evaluating eganelisib in the anti-PD-1 refractory, I/O-naïve, and front-line settings. For more information on Infinity, please refer to Infinity's website at www.infi.com.
Location: United States, Massachusetts, Cambridge
Member count: 11-50
Founded date: 2001
Investors 5
Date | Name | Website |
07.08.2021 | New Enterp... | nea.com |
- | Aisling Ca... | aislingcap... |
- | Prospect V... | prospectve... |
- | Advent Lif... | adventls.c... |
- | Koa Labs | koalab.com |
Mentions in press and media 3
Date | Title | Description | Category | Author | Source |
09.01.2020 | Infinity P... | CAMBRIDGE, Mass.--(BUSINESS WI... | - | - | citybizlis... |
05.05.2009 | Group Name... | Share Share on Facebook Share ... | - | Wade Roush | xconomy.co... |
- | Discovered... | Eros Dervishi for STAT PHILAD... | - | - | statnews.c... |